Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)

CUSIP: 61225M102

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Security type / class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
84,039,109
Holder snapshot
Total 13F shares
60,027,627
Share change
-2,173,827
Total reported value
$444,802,878
Put/Call ratio
170%
Reported price per share
$7.41
Number of holders
126
Value change
-$4,386,129
Number of buys
58
Number of sells
55

Security key

61225M102

Report period

Q3 2025

Institutions

126

Top holders

10

GLUE full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Monte Rosa Therapeutics, Inc. SEC filings Monte Rosa Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
PRICE T ROWE ASSOCIATES I...
13D/G signal
PRICE T ROWE ASSOCIATES I...
Evidence rows
15
Latest as of
30 Sep 2025
13D/G 13F Lead comparable stake: 7.5% 13D/G row: PRICE T ROWE ASSOCIATES INC /MD/ Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
13D/G 13F
7.5%
$34,360,615
4,637,060 shares
 $0 30 Sep 2025
BlackRock, Inc.
13D/G 13F
Company
13D/G 13F
6.3%
$20,045,661
3,840,165 shares
 $0 31 Dec 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 13F
Company
13D/G 13F
5.5%
$17,539,200
3,360,000 shares
 $0 09 Apr 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
13D/G 13F
4.8%
$22,148,142
2,988,953 shares
 -$1,240,441 30 Sep 2025
FMR LLC
13F 13D/G
Company
13F 13D/G
2.8%
from 13D/G
$10,319,033
2,288,034 shares
 — 30 Jun 2025
NEA Management Company, LLC
13F
Company
13F
9.2%
$34,692,264
7,692,298 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
126
Shares
60,027,627
Rows available
126
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
115
Q3 2025 holders
126
Holder diff
11
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .